Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it ...

Harrow plans to submit a New Drug Application (“NDA”) to the FDA in 2027, with a potential U.S. commercial launch in 2028.

The acquisition will include Melt’s lead investigational therapy, MELT-300, designed to provide rapid, predictable sedation ...

Harrow (NASDAQ:HROW) to acquire Melt Pharmaceuticals, a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for medical procedures in the hospital, outpatient, ...

Netherlands: Midazolam sedation can noticeably restrict the natural adaptability of breathing, while s-ketamine largely ...

A 2024 Associated Press investigation into in-custody deaths examined 94 cases nationally involving forced sedation between 2012 and 2021 ... knelt down and injected him in the buttocks with midazolam ...

The new head of the Fort Monroe Foundation is looking to turn the historic fort into a park of the future. Aazia Mrozinski, a leader experienced in innovation and community-building, took the reins as ...

Objective: To identify and study the existing literature on the efficacy and safety of midazolam compared to inhalation of nitrous oxide in children undergoing dental treatment. Material and Methods: ...

Midazolam and fentanyl combination therapy may provide more comfort, fewer adverse events, and a shorter recovery time than midazolam and meperidine. Conscious sedation with midazolam and an opioid is ...

“It’s so fun to be a fan of the zodiac killer in pop star form,” a Swiftie named Lacey wrote on X a few hours before the official announcement of the new album arrived today at 12:12 a.m. EST. “The ...

Scientists have shown the efficacy of a new non-opioid oral painkiller known as ADRIANA, the world's first selective α2B-adrenoceptor antagonist – a receptor subtype not previously targeted for ...